| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2009 | EP1931342A4 Anesthesia induction and maintenance drug |
| 07/15/2009 | EP1874304B1 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 07/15/2009 | EP1871738B1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 07/15/2009 | EP1865969A4 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells |
| 07/15/2009 | EP1846058B1 Device method, and use for treatment of neuropathy involving nitric oxide |
| 07/15/2009 | EP1844039B1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics |
| 07/15/2009 | EP1831240B1 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 07/15/2009 | EP1794172B1 Antiviral 4'-azido-nucleosides |
| 07/15/2009 | EP1773362A4 Solvent based plant extracts |
| 07/15/2009 | EP1761243B1 Tobacco alkaloid releasing chewing gum |
| 07/15/2009 | EP1752162B1 Collagen-polyvinylpyrrolidone for the treatment of osteoarthritis |
| 07/15/2009 | EP1750664B1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
| 07/15/2009 | EP1744758A4 Radiopharmaceutical and methods of synthesis and use thereof |
| 07/15/2009 | EP1741430B1 Remedy for psychoneurotic diseases |
| 07/15/2009 | EP1740587A4 Selective antagonists of a-2a- adenosine receptors |
| 07/15/2009 | EP1709005B1 High purity butoconazole nitrate with specified particle size and a process for preparation thereof |
| 07/15/2009 | EP1706106B1 Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances |
| 07/15/2009 | EP1675625A4 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/15/2009 | EP1662908B1 Composition and method for facilitating bone healing |
| 07/15/2009 | EP1653989B1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 07/15/2009 | EP1651190A4 Formulations containing an immune response modifier |
| 07/15/2009 | EP1624871B1 Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions |
| 07/15/2009 | EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/15/2009 | EP1389118B1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle |
| 07/15/2009 | EP1379514B1 5-membered heterocycles, preparation and application thereof as medicaments |
| 07/15/2009 | EP1370268B1 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 07/15/2009 | EP1328263B1 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 07/15/2009 | EP1299109B1 Bifunctional antibiotics |
| 07/15/2009 | EP1292381B1 Process and device for producing liquid dosage formulations |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1261335B1 Combination of n-acetyl-l-tryptophan and magnesium sulphate for the treatment of brain, spinal and nerve injury |
| 07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | EP1063971B1 Controlled release oral tablet having a unitary core |
| 07/15/2009 | CN101484177A Ophthalmic composition containing alginic acid or salt thereof |
| 07/15/2009 | CN101484176A Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 07/15/2009 | CN101484175A Nootropic medicinal agent |
| 07/15/2009 | CN101484174A Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 07/15/2009 | CN101484173A Pharmaceutical combinations of pk inhibitors and other active agents |
| 07/15/2009 | CN101484172A Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315ile kinase inhibitor |
| 07/15/2009 | CN101484171A Amino acid surrogates for peptidic constructs |
| 07/15/2009 | CN101484170A Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| 07/15/2009 | CN101484169A Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| 07/15/2009 | CN101484168A Use of derivatives of imidazo[1, 2-a]pyridine-2-carboxamides in therapeutics |
| 07/15/2009 | CN101484166A Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 07/15/2009 | CN101484165A Methods and composition for treatment of inflammatory pain |
| 07/15/2009 | CN101484164A Use of 2-benzoyl-imidazopyridines in therapeutics |
| 07/15/2009 | CN101484163A Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics |
| 07/15/2009 | CN101484162A Use of combination preparations comprising antifungal agents |
| 07/15/2009 | CN101484161A Cannabinoid receptor antagonists/iN. V.erse agonists |
| 07/15/2009 | CN101484160A Photosensitizer containing indole-3-alkylcarboxylic acid, and kit for photodynamic therapy containing the same |
| 07/15/2009 | CN101484159A Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist |
| 07/15/2009 | CN101484158A Senescence inhibitor |
| 07/15/2009 | CN101484157A Agent for improving muscle power |
| 07/15/2009 | CN101484156A Histone deacetylase and tubulin deacetylase inhibitors |
| 07/15/2009 | CN101484155A Naphthalenedione compounds |
| 07/15/2009 | CN101484154A Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid |
| 07/15/2009 | CN101484153A Gastric retentive gabapentin dosage forms and methods for using same |
| 07/15/2009 | CN101484152A Therapeutic combination for painful medical conditions |
| 07/15/2009 | CN101484151A Bivalent SMAC mimetics and the uses thereof |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN101481356A Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 07/15/2009 | CN101480408A Nutrient health-care liquid for coloclysis |
| 07/15/2009 | CN101480407A Hyaluronidase inhibitor as well as preparation method and use thereof |
| 07/15/2009 | CN101480406A 24-methylene cycloartenyl ferulate composition and method for preparing the same |
| 07/15/2009 | CN101480405A Oryzanol composition and preparation method thereof |
| 07/15/2009 | CN101480404A Medicinal product of oryzanol and preparation method thereof |
| 07/15/2009 | CN101480403A Medicament composition and preparation method thereof |
| 07/15/2009 | CN101480402A Cycloartenyl ferulate composition and method for preparing the same |
| 07/15/2009 | CN101480401A Medroxyprogesterone acetate tablet and preparation method thereof |
| 07/15/2009 | CN101480400A Novel medical use of estrone derivate EA303 |
| 07/15/2009 | CN101480399A Application of andrusol in preparing medicament for treating asthenospermia |
| 07/15/2009 | CN101480398A Use of ivabradine for the treatment of endothelial dysfunction |
| 07/15/2009 | CN101480397A Cefixime orally disintegrating tablet and preparation method thereof |
| 07/15/2009 | CN101480396A Spawning-induced addition agent for artificial propagation of sea water fish |
| 07/15/2009 | CN101480395A Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen |
| 07/15/2009 | CN101480394A Anti-tumor pharmaceutical composition |
| 07/15/2009 | CN101480393A Application of bulleyaconitine A in preparing medicament for treating Nav1.7 ache disease |
| 07/15/2009 | CN101480392A Application of bulleyaconitine A in preparing medicament for treating ache related to sodium channel |
| 07/15/2009 | CN101480391A Application of sophocarpine in preparing medicament for treating disease induced by coxsachie A virus |
| 07/15/2009 | CN101480390A Compound preparation containing Sartan and diuretics |
| 07/15/2009 | CN101480389A Compound for treating primary dysmenorrhea |
| 07/15/2009 | CN101480388A Application of kalamycin as topoisomerase II inhibitor |
| 07/15/2009 | CN101480387A Aceclofenac pharmaceutical composition |
| 07/15/2009 | CN101480386A Method for applying calcium polyenoic acid for medical and beauty treatment fields |
| 07/15/2009 | CN101480385A Use of methionine |
| 07/15/2009 | CN101480384A Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| 07/15/2009 | CN101480383A Application of disodium sulfodehydroabietate for treating gastroxia type peptic ulcer and gastrointestinal tract inflammation |
| 07/15/2009 | CN101480382A Pharmaceutical composition for treating acute and chronic nasal sinusitis and preparation method thereof |
| 07/15/2009 | CN101480381A Coenzyme Q10 pharmaceutical composition |
| 07/15/2009 | CN101480380A General anesthetic for intravenous injection and preparation method |
| 07/15/2009 | CN101480376A Method of preparing particles for agglomeration |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/15/2009 | CN100513404C Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |